Ductal Carcinoma in Situ of the Breast
📧 Sign up to get email alerts when something new happens for Ductal Carcinoma in Situ of the Breast.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
This clinical trial update reports demographics, characteristics, and outcomes of male breast cancer patients treated at Methodist Health Sy…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ [Phase 1]
Phase 1 clinical trial evaluating H2NVAC, a vaccine, before surgery for HER2-expressing ductal carcinoma in situ of the breast; study curren…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CONFIRM: Magnetic Resonance Guided Radiation Therapy [NA]
ClinicalTrials.gov study CONFIRM is evaluating magnetic resonance guided radiation therapy and is currently recruiting for several cancers, …
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast [Phase 2]
A Phase 2 clinical trial update reports wide excision alone as a treatment option for ductal carcinoma in situ of the breast; the study is c…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer [Phase 2]
A Phase 2 study comparing 5-day versus 9-day courses of whole breast radiotherapy with a boost for early-stage breast cancer; the trial is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial [NA]
A clinical trial aims to assess whether endocrine therapy can avoid surgery for estrogen receptor–positive atypical ductal hyperplasia and d…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery [Phase 2]
Phase 2 trial evaluating preoperative palbociclib in patients with ductal carcinoma in situ of the breast who are surgical candidates was te…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: PBI for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment [NA]
A clinical trial update for partial breast irradiation as local adjuvant treatment in intermediate-low risk ductal carcinoma in situ of the …
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy [Phase 3]
A Phase 3 trial investigated whether adding trastuzumab to radiation therapy improves outcomes for women with ductal carcinoma in situ after…
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ [Phase 2]
Phase 2 trial evaluating letrozole in postmenopausal women with ductal carcinoma in situ of the breast has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast [Phase 1]
Phase 1 trial evaluating vorinostat for ductal carcinoma in situ of the breast has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery [Phase 2]
A Phase 2 trial evaluating radiation therapy in postmenopausal women with early-stage breast cancer undergoing surgery was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast [Phase 2]
Phase 2 trial update reporting ten-year results of a scoring system to guide adjuvant therapies after breast-conserving surgery for ductal c…
-
CLINICAL_TRIALS research · 2015-11-30Clinical Trial Update: Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery
Sponsored by Fudan University, this trial investigates partial breast irradiation for low-risk ductal carcinoma in situ after breast-conserv…
-
CLINICAL_TRIALS research · 2015-03-17Clinical Trial Update: Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer [NA]
This clinical trial update notes the ongoing recruitment for a study evaluating intra-operative radiotherapy for ductal carcinoma in situ of…
-
CLINICAL_TRIALS research · 2015-03-17Clinical Trial Update: Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Ductal Carcinoma in Situ [NA]
A clinical trial is comparing intra-operative radiotherapy with post-operative radiotherapy in women with ductal carcinoma in situ of the br…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast [NA]
This clinical trial update compares fulvestrant and tamoxifen in postmenopausal women undergoing surgery for ductal carcinoma in situ of the…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast [Phase 2]
A Phase 2 clinical trial evaluating gefitinib followed by surgery for ductal carcinoma in situ of the breast was terminated.